Third Cycle Programmes
    (Doctorate Degree)
Second Cycle Programmes
    (Master's Degree)
First Cycle Programmes
    (Bachelor's Degree)
Short Cycle Programmes
    (Associate's Degree)
 
Second Cycle Programmes (Master's Degree)

Graduate School of Health Sciences - Pharmaceutical Biotechnology - Second Cycle Programme with Thesis



General Description
History
Ege University/Graduate School of Health Sciences/ Pharmaceutical Biotechnology Department
Qualification Awarded
Master Degree
Level of Qualification
Second Cycle
Specific Admission Requirements
The applicants who hold a Bachelor's Degree and willing to enroll in the Master's programme may apply to the Directorate of the Graduate School with the documents: 1-Sufficient score (at least 55 out of 100) from the Academic Staff and Graduate Study Education Exam (ALES) conducted by Student Selection and Placement Center (OSYM) or GRE Graduate Record Examination (GRE) score or Graduate Management Admission Test (GMAT) score equivalent to ALES score of 55. 2-English proficiency (at least 70 out of 100 from the Profiency Exam conducted by Ege University Foreign Language Department, or at least 50 out of 100 from ÜDS (University Language Examination conducted by OSYM) or TOEFL or IELTS score equivalent to UDS score of 50. The candidates fulfilling the criteria outlined above are invited to interwiev. The assessment for admission to masters programs is based on : 50% of ALES, 25% of academic success in the undergraduate programme (cumulative grade point average (CGPA) ) and 25% of interview grade. The required minimum interview grade is 50 out of 100. The candidates having an assessed score of 60 at least are accepted into the Master's programme. The results of the evaluation are announced by the Directorate of Graduate School.
Specific Arrangements For Recognition Of Prior Learning (Formal, Non-Formal and Informal)
The rules for recognition of formal prior learning are well defined. A student who is currently enrolled in a Master's Degree programme in the same discipline at another institution and has successfully completed at least one semester, upon submitting all required documents before the deadline, may transfer to the Master's Programme at EGE University upon the recommendation of the department administration and with the approval of the Administrative Committee of the Graduate School. The decision taken will also include eligibility for exemption from some course requirements of the graduate program. Students who transfer from another university must be successful in the EGE University English Proficiency Exam or in an equivalent English examination. Recognition of prior non-formal and in-formal learning is at the beginning stage in Turkish Higher Education Institutions. Ege University is not an exception to this.
Qualification Requirements and Regulations
The programme consists of a minimum of seven courses delivered within the graduate programme of the department and in related fields, one seminar course, and thesis, with a minimum of 21 local credits. The seminar course and thesis are non-credit and graded on a pass/fail basis. The duration of the programme is four semesters. The maximum period to complete course work in a masters program with thesis is 4 semesters. However, with the approval of their advisors, students can in subsequent semesters take additional departmental courses with or without credits. The total ECTS credits of the programme is 120 ECTS. A student may take undergraduate courses on the condition that the courses have not been taken during the undergraduate program. However, at most two of these courses may be counted to the Master's course load and credits. Students must register for thesis work and the Specialization Field course offered by his supervisor every semester following the semester, in which the supervisor is appointed. A student who has completed work on the thesis within the time period, must write a thesis, using the data collected, according to the specifications of the Graduate School Thesis Writing Guide. The thesis must be defended in front of a jury. The Master's thesis jury is appointed on the recommendations of the relevant Department Chairperson and with the approval of the Administrative Committee of the Graduate School. The jury is composed of the thesis supervisor and 3 to 5 faculty members. Of the appointed jury members, up to one may be selected from another Department or another University. In case the jury consists of 3 members, the co-supervisor cannot be the jury member. A majority vote by the jury members determines the outcome of the thesis or examination. The vote can be for "acceptance", "rejection" or "correction". The Department Chairperson will inform the Director of the Graduate School, in writing, of the jury's decision within 3 days. To correct or change a thesis found incomplete and/or inadequate by the jury, the jury must specify in its report that such corrections are necessary. A student may be given, by a decision of the Administrative Committee of the Graduate School, up to three months to complete the corrections. The student must then retake the thesis examination.
Profile of The Programme
Program comprises compulsory and optional lessons about designing new therapeutic drugs and delivery systems, production of peptides and proteins by recombinant DNA technology, formulation of proteins and DNA vaccines.
Occupational Profiles of Graduates With Examples
Graduates who successfully completed the Master's Degree may find jobs at biotechnology companies, R&D laboratories, drug quality control departments and authorization departments.
Access to Further Studies
Graduates who successfully completed the Master's Degree may apply to doctorate (third cycle) programmes in the same or in related disciplines.
Examination Regulations, Assessment and Grading
40% of mean intermediate examination plus 60% of final exam
Graduation Requirements
Graduation requirements are explained in the section “Qualification Requirements and Regulations” .
Mode of Study (Full-Time, Part-Time, E-Learning )
Full-Time
Address, Programme Director or Equivalent
Prof. Dr. Zeki Topçu Adress: Ege University, Faculty of Pharmacy Pharmaceutical Biotechnology Department Bornova/ Izmir/ TURKEY e-mail: zeki.topcu@ege.edu.tr Tel: +90 232 3111010-(1931)
Facilities
There are sufficient equipments for pharmaceutical formulation development and molecular biology applications.

Key Learning Outcomes
1Using pharmaceutical biotechnology and combining it with pharmaceutical approaches
2Having thorough knowledge and enforceability of development, research and production of pharmaceutical and medical products
3Gaining team work and mutual laboratory tasks and calculating the practical application processes.
4Combining pharmaceutical biotechnology with other scientific diciplines and creating a multidiciplinary research area.
5Having the knowledge of production of pharmaceutical products and controlling their qualities
6Carrying out the pharmaceutical biotechnology application protocols and analizing the results.
7Capability to use the knowledge of pharmaceutical biotechnology for social benefits.
8To be aware of universal and national health problems concerning with pharmaceutical biotechnology
9To be responsible for life long learning and updating the knowledge.
10To be able to use foreign language in pharmaceutical biotechnology laboratory and communicate with foreign colleagues.
11To have the knowledge of molecular biology methods and applications.
12Developing application strategies and practical abilities in molecular biology.

Key Programme Learning Outcomes - NQF for HE in Turkey
TYYÇKey Learning Outcomes
123456789101112
KNOWLEDGE1
2
SKILLS1
2
3
COMPETENCES (Competence to Work Independently and Take Responsibility)1
2
3
COMPETENCES (Learning Competence)1
COMPETENCES (Communication and Social Competence)1
2
3
4
COMPETENCES (Field Specific Competence)1
2
3

Course Structure Diagram with Credits
T : Theoretical P: Practice L : Laboratory
1. Semester
No Course Unit Code Course Unit Title Type of Course T P L ECTS
1 930313SEÇ.YL1 ELECTIVE COURSES Elective - - - 18
2 9303135012006 Rekombinant DNA Technology Compulsory 3 2 0 12
Total 3 2 0 30
 
2. Semester
No Course Unit Code Course Unit Title Type of Course T P L ECTS
1 9303135022006 Applications of Rekombinant DNA Technology Compulsory 2 4 0 12
2 930313SEÇ.YL2 ELECTIVE COURSES Elective - - - 9
3 BAT102 Fundamentals of Scientific Research Compulsory 2 0 0 3
4 SBEYLSEM500 Seminar Compulsory 0 0 0 6
Total 4 4 0 30
 
3. Semester
No Course Unit Code Course Unit Title Type of Course T P L ECTS
1 SBEYLUAD501 Specialization Field Course Compulsory 0 0 0 4
2 SBEYLTEZ501 Thesis Compulsory 0 0 0 26
Total 0 0 0 30
 
4. Semester
No Course Unit Code Course Unit Title Type of Course T P L ECTS
1 SBEYLUAD502 Specialization Field Course Compulsory 0 0 0 4
2 SBEYLTEZ502 Thesis Compulsory 0 0 0 26
Total 0 0 0 30
 
ELECTIVE COURSES
No Course Unit Code Course Unit Title Type of Course T P L ECTS
1 9303135081999 Special Methods in Pharmaceutical Biotechnology II Elective 2 2 0 8
2 9303135092006 Advenced Moleculer Biology Elective 3 0 0 6
3 9303135102006 Immunotherapeutical Products and Technology Elective 3 0 0 6
4 9303135151999 Special Methods in Pharmaceutical Biotechnology I Elective 2 2 0 8
5 9303135202003 Pharmacogenomics Elective 3 0 0 6
6 9303135232003 Computational Biostatistics I Elective 3 0 0 6
7 9303135252006 Drug Delivery Systems in Pharmaceutical Biotechnology I Elective 3 0 0 6
8 9303135262006 Drug Delivery Systems in Pharmaceutical Biotechnology II Elective 3 0 0 6
9 9303135272006 Manufactoring nad Application Principles in Pharmaceutical Biotechnology Elective 3 0 0 6
10 9303135322012 Laboratuvar Güvenliğine Giriş Elective 3 0 0 6
11 9303135332016 Intracelluar Signal Transduction Pathways Elective 3 0 0 6
12 9303135342016 Therapeutic Proteins Elective 3 0 0 6
13 9303135352016 Poratein Analyse Methods Elective 3 0 0 4
14 9303135362016 Biosimilar Products Elective 3 0 0 4
ELECTIVE COURSES
No Course Unit Code Course Unit Title Type of Course T P L ECTS
1 9303135081999 Special Methods in Pharmaceutical Biotechnology II Elective 2 2 0 8
2 9303135092006 Advenced Moleculer Biology Elective 3 0 0 6
3 9303135102006 Immunotherapeutical Products and Technology Elective 3 0 0 6
4 9303135151999 Special Methods in Pharmaceutical Biotechnology I Elective 2 2 0 8
5 9303135202003 Pharmacogenomics Elective 3 0 0 6
6 9303135232003 Computational Biostatistics I Elective 3 0 0 6
7 9303135252006 Drug Delivery Systems in Pharmaceutical Biotechnology I Elective 3 0 0 6
8 9303135262006 Drug Delivery Systems in Pharmaceutical Biotechnology II Elective 3 0 0 6
9 9303135272006 Manufactoring nad Application Principles in Pharmaceutical Biotechnology Elective 3 0 0 6
10 9303135322012 Laboratuvar Güvenliğine Giriş Elective 3 0 0 6
11 9303135332016 Intracelluar Signal Transduction Pathways Elective 3 0 0 6
12 9303135342016 Therapeutic Proteins Elective 3 0 0 6
13 9303135352016 Poratein Analyse Methods Elective 3 0 0 4
14 9303135362016 Biosimilar Products Elective 3 0 0 4
 
Ege University, Bornova - İzmir / TURKEY • Phone: +90 232 311 10 10 • e-mail: intrec@mail.ege.edu.tr